These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Martin DF, Hollanders D, May SJ, Ravenscroft MM, Tweedle DE, Miller JP. Lancet; 1981 Jan 03; 1(8210):7-10. PubMed ID: 6109102 [Abstract] [Full Text] [Related]
3. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine. Lam SK, Lee NW, Koo J, Hui WM, Fok KH, Ng M. Gut; 1984 Jul 03; 25(7):703-6. PubMed ID: 6376292 [Abstract] [Full Text] [Related]
4. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Hamilton I, O'Connor HJ, Wood NC, Bradbury I, Axon AT. Gut; 1986 Jan 03; 27(1):106-10. PubMed ID: 3512382 [Abstract] [Full Text] [Related]
5. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer. Hamilton I, Worsley BW, O'Connor HJ, Axon AT. Gut; 1983 Dec 03; 24(12):1148-51. PubMed ID: 6357964 [Abstract] [Full Text] [Related]
6. [Cimetidine and tripotassium-dicitrato bismuthate (Duosol) in chronic duodenal ulcer]. Bergoz R. Schweiz Med Wochenschr; 1985 Jul 20; 115(29):1024-5. PubMed ID: 4048901 [Abstract] [Full Text] [Related]
7. Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers. Bianchi Porro G, Parente F, Lazzaroni M. Gut; 1987 Jul 20; 28(7):907-11. PubMed ID: 3308650 [Abstract] [Full Text] [Related]
8. Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment. Bianchi Porro G, Lazzaroni M, Petrillo M, Ardizzone S, Manzionna G, Caruso I, Montrone F. Aliment Pharmacol Ther; 1998 Apr 20; 12(4):343-7. PubMed ID: 9690723 [Abstract] [Full Text] [Related]
9. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse. Sutton DR. Gut; 1982 Jul 20; 23(7):621-4. PubMed ID: 7044913 [Abstract] [Full Text] [Related]
14. Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration. Hollanders D. Postgrad Med J; 1986 Jan 20; 62(723):19-21. PubMed ID: 3540918 [Abstract] [Full Text] [Related]
16. Treatment of chronic duodenal ulceration. Effectiveness of colloidal bismuth subcitrate tablets compared with cimetidine. Harley H, Alp MH. Med J Aust; 1986 Jan 20; 2(12):627-8. PubMed ID: 6366498 [Abstract] [Full Text] [Related]
17. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer. Chearanai O, Kachintorn U, Plengvanit U. J Med Assoc Thai; 1987 Apr 20; 70(4):176-80. PubMed ID: 3612003 [No Abstract] [Full Text] [Related]
18. Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer. Vantrappen G, Rutgeerts P, Broeckaert L, Janssens J. Gut; 1980 Apr 20; 21(4):329-33. PubMed ID: 7000628 [Abstract] [Full Text] [Related]
19. Likelihood of relapse of duodenal ulcer after initial treatment with cimetidine or colloidal bismuth subcitrate. Miller JP, Hollanders D, Ravenscroft MM, Tweedle DE, Martin DF. Scand J Gastroenterol Suppl; 1982 Apr 20; 80():39-42. PubMed ID: 6761851 [Abstract] [Full Text] [Related]